- Active not recruitingPHASE1
Phase I Comparative Bioavailability Study
This study looks at how the body uses a new cancer medicine, AZD2281, when given in two different ways. It's for people with advanced solid tumors who have already tried other treatments.
For: Solid TumorsAustralia · Belgium · Switzerland - Ongoing, recruitingHuman Pharmacology (Phase I)- Other
A Phase I, Open-label, Parallel Group Study to Investigate Olaparib Safety and Tolerability, Efficacy and Pharmacokinetics in Paediatric Patients with Solid Tumours
This study is looking at a medicine called olaparib (also known as Lynparza) in children and young people with solid tumours. We want to see how safe it is, how well it's tolerated, and how the body handles it. This helps us find the right dose for future use.
For: solid tumorsItaly · Denmark · Hungary